当前位置:首页 - 行情中心 - 力诺药包(301188) - 财务分析 - 现金流量表

力诺药包

(301188)

  

流通市值:40.57亿  总市值:40.57亿
流通股本:2.39亿   总股本:2.39亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金575,386,996.23375,946,773.32174,076,729.39825,930,185.97
  收到其他与经营活动有关的现金61,013,332.1556,609,317.676,616,478.3873,625,558.73
  经营活动现金流入小计636,400,328.38432,556,090.99180,693,207.77899,555,744.7
  购买商品、接受劳务支付的现金469,686,626.53289,572,407.81120,052,857.77497,242,985.1
  支付给职工以及为职工支付的现金149,157,162.22102,278,642.6246,441,474.96202,254,326.98
  支付的各项税费24,736,423.8219,418,443.627,485,484.7418,699,704.98
  支付其他与经营活动有关的现金53,292,384.0530,891,675.9722,011,664.4158,350,479.02
  经营活动现金流出小计696,872,596.62442,161,170.02195,991,481.88776,547,496.08
  经营活动产生的现金流量净额-60,472,268.24-9,605,079.03-15,298,274.11123,008,248.62
二、投资活动产生的现金流量:
  取得投资收益收到的现金2,528,686.241,634,288.221,505,243.2310,757,449.52
  处置固定资产、无形资产和其他长期资产收回的现金净额8,836,140.88,836,140.8-442,866.27
  收到的其他与投资活动有关的现金520,643,827.27330,000,000309,886,3002,882,400,526.21
  投资活动现金流入小计532,008,654.31340,470,429.02311,391,543.232,893,600,842
  购建固定资产、无形资产和其他长期资产支付的现金236,274,100.1488,068,576.7933,464,559.46209,555,723.42
  投资支付的现金84,000,000---
  支付其他与投资活动有关的现金290,341,999.99230,300,00090,000,0002,752,233,281.58
  投资活动现金流出小计610,616,100.13318,368,576.79123,464,559.462,961,789,005
  投资活动产生的现金流量净额-78,607,445.8222,101,852.23187,926,983.77-68,188,163
三、筹资活动产生的现金流量:
  取得借款收到的现金78,482,00047,000,00027,000,00015,000,000
  收到其他与筹资活动有关的现金8,620,350.926,500,0003,217,163.95-
  筹资活动现金流入小计87,102,350.9253,500,00030,217,163.9515,000,000
  偿还债务支付的现金1,000.55---
  分配股利、利润或偿付利息支付的现金26,665,263.9923,169,001.86138,449.9924,480,806.1
  支付其他与筹资活动有关的现金51,677,662.8650,264,635.0118,753,449.1850,029,878.04
  筹资活动现金流出小计78,343,927.473,433,636.8718,891,899.1774,510,684.14
  筹资活动产生的现金流量净额8,758,423.52-19,933,636.8711,325,264.78-59,510,684.14
四、汇率变动对现金及现金等价物的影响---2,097,602.35
五、现金及现金等价物净增加额-130,321,290.54-7,436,863.67183,953,974.44-2,592,996.17
  加:期初现金及现金等价物余额400,746,376.99400,746,376.99403,339,373.16403,339,373.16
  期末现金及现金等价物余额270,425,086.45393,309,513.32587,293,347.6400,746,376.99
补充资料:
  净利润-40,967,465.56-66,067,595.87
  资产减值准备-4,532,820.54-11,067,217.36
  固定资产和投资性房地产折旧-56,191,084.12-104,250,095.73
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-56,191,084.12-104,250,095.73
  无形资产摊销-1,006,034.82-1,599,760.06
  长期待摊费用摊销-1,566,486.1-3,900,820.3
  处置固定资产、无形资产和其他长期资产的损失--2,380,717.62--20,945.09
  固定资产报废损失-6,037.5-641,566.48
  公允价值变动损失--1,105,578.17--1,454,305.47
  财务费用-13,152,143.83-23,458,754.53
  投资损失--4,259,251.16--11,776,620.71
  递延所得税--5,717,602.09--6,811,340.83
  其中:递延所得税资产减少--3,465,303.76-3,021,715.38
    递延所得税负债增加--2,252,298.33--9,833,056.21
  存货的减少--78,084,712.51--77,534,046.37
  经营性应收项目的减少--31,536,731.56--174,949,823.78
  经营性应付项目的增加--4,196,435.25-184,569,520.54
  现金的期末余额-393,309,513.32-400,746,376.99
  减:现金的期初余额-400,746,376.99-403,339,373.16
  现金及现金等价物的净增加额--7,436,863.67--2,592,996.17
公告日期2025-10-282025-08-212025-04-252025-04-25
审计意见(境内)标准无保留意见
TOP↑